Local/Staging environment
Lot 16
Italian (1927-2012)
Untitled (Fruit Stand) (1966)
Medium

oil on canvas

Dimensions

39 1/2 x 43 1/2 inches

Signature

signed lower right

Estimate: $3,000 - $5,000

Have one like this?

Frame Information

frame dimensions: 47 1/2 x 51 1/2 x 3 inches, wood frame

Provenance

From the Collection of Memorial Sloan Kettering Cancer Center

Condition

overall good condition, with 1/2 inch puncture to watermelon on middle right side

Nicola Simbari

Italian 1927-2012

Mario Bellini is an architect and designer known for his influential contributions to the fields of architecture, industrial design, and furniture design.


Bellini has designed a wide range of products, including furniture, lighting, and consumer electronics. He has collaborated with renowned companies such as Olivetti, Cassina, Vitra, and Artemide. His designs are known for their innovative use of materials and forms, emphasizing both functionality and beauty.


Mario Bellini's contributions to design have earned him numerous awards and accolades throughout his career. He received the prestigious Compasso d'Oro (Golden Compass) award multiple times.


A selection from

Memorial Sloan Kettering Cancer Center

Image for Collection Memorial Sloan Kettering Cancer Center

Proceeds from this sale will directly benefit The Society of MSK, which was founded in 1946 by a group of forward-thinking women dedicated to enhancing the hospital environment and level of patient support that have always been the hallmarks of MSK. Today, the Society has evolved into a full partner of MSK as an internationally renowned organization involved in both policy and fundraising in support of research, patient care programs and education. 


Memorial Sloan Kettering Cancer Center is the world's oldest and largest private cancer center, providing comprehensive care to patients from all walks of life. Renowned for its cutting-edge research, innovative treatments, and compassionate approach to care, Memorial Sloan Kettering Cancer Center is dedicated to making progress against cancer and improving outcomes for patients worldwide.